Neutral
Last updated: 2026-06-24 09:19:46 ET
Pulse AI Brief
Updated Jun 24, 2026 9:00 AM ET
Daniel Cressy, 23, has become the first person in Louisiana to achieve functional cure of sickle cell disease through gene therapy. The breakthrough demonstrates the clinical viability of curative approaches for a disease that has historically required lifelong management.
Gene therapy companies developing sickle cell treatments (Vertex Pharmaceuticals, CRISPR Therapeutics, Bluebird Bio) gain clinical validation and potential for expanded patient populations. Success cases accelerate reimbursement discussions and de-risk commercial adoption of curative therapies.
The case exemplifies the shift from chronic disease management to curative medicine and validates CRISPR-based approaches for genetic disorders. It also raises questions about access and pricing for curative therapies, likely triggering policy debates around healthcare equity and drug pricing.
Gen. Chris Donahue had clashed with Defense Secretary Pete Hegseth, multiple sources told CBS News.
Attack targeted former Chile ambassador Orlando Letelier and his US colleague Ronni Karpen MoffittFifty years after Gen Augusto Pinochet’s secret po...
Lt. Gen. Keith Kellogg urged Iranian dissidents at a Paris NCRI gathering to seize a historic opening, saying the Tehran regime is weaker than ever.
Wine marketers are shaking things up to attract younger drinkers
The mixed messages on AI are another challenge when Gen Z already faces a tough job market.
At age 24, workers born in the late 1990s are paid more than any cohort since those born in the 1950sGen Z’s early careers are more financially rewa...
Gen Z and millennial professionals are avoiding phone calls — and paying a price at work
Five actionable steps for “motivated yet underinformed” young adults to build their credit — and their confidence.
Because of HIMARS, Maj. Gen. Bartholomees pointed out his “division artillery is really what transformed the most.”
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE